SCHEMBL363440

SCHEMBL363440

C#CCCC(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27404136 0.98
Hydrochloric Acid SCHEMBL28192824 0.98
SCHEMBL1444871 0.86
Ammonia Solution, Strong SCHEMBL17749604 0.84 TSHR (0.58)
SCHEMBL5153957 0.84 TSHR (0.58)
SCHEMBL12561231 0.84 TSHR (0.44)
SCHEMBL17981462 0.82 MAPT (0.57)
SCHEMBL22836423 0.82 MAPT (0.57)
SCHEMBL15541706 0.82 MAPT (0.57)
SCHEMBL2467407 0.82 MAPT (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 689 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116903866-B Polyvinyl alcohol modified multifunctional powder slump retaining agent and preparation method thereof JIANGSU ARIT NEW MATERIALS CO.,LTD. (CN) 2026-05-26 CN claimed
CN-113698394-B Propiconazole hapten as well as preparation method and application thereof 南京农业大学 2023-12-15 CN claimed
CN-116903866-A Polyvinyl alcohol modified multifunctional powder slump retaining agent and preparation method thereof 江苏奥莱特新材料股份有限公司 2023-10-20 CN claimed
CN-113698394-A Propiconazole hapten as well as preparation method and application thereof 南京农业大学 2021-11-26 CN claimed
US-20140336397-A1 METHODS FOR THE SYNTHESIS OF 13C LABELED DHA AND USE AS A REFERENCE STANDARD MED-LIFE DISCOVERIES LP (CA) 2014-11-13 US claimed
EP-2688868-A1 METHOD FOR THE SYNTHESIS OF DHA Phenomenome Discoveries Inc. (CA) 2014-01-29 EP claimed
US-20140012024-A1 METHOD FOR THE SYNTHESIS OF DHA PHENOMENOME DISCOVERIES INC. (CA) 2014-01-09 US claimed
WO-2013071411-A1 METHODS FOR THE SYNTHESIS OF 13C LABELED DHA AND USE AS A REFERENCE STANDARD PHENOMENOME DISCOVERIES INC. (CA) 2013-05-23 WO claimed
WO-2012126088-A1 METHOD FOR THE SYNTHESIS OF DHA PHENOMENOME DISCOVERIES INC. (CA) 2012-09-27 WO claimed
CN-116903866-B Polyvinyl alcohol modified multifunctional powder slump retaining agent and preparation method thereof JIANGSU ARIT NEW MATERIALS CO.,LTD. (CN) 2026-05-26 CN disclosed
WO-2026107406-A1 p53 HETEROBIFUNCTIONAL CONJUGATES AND USES THEREOF Design Therapeutics, Inc. (US) 2026-05-21 WO disclosed
US-12570672-B2 Macrocyclic compounds and methods of use AMGEN INC. 2026-03-10 US disclosed
EP-4678643-A1 KRAS INHIBITOR COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2026-01-14 EP disclosed
US-12522612-B2 PDE4 inhibitors, pharmaceutical compositions, and therapeutic applications BIOTHERYX INC. (US) 2026-01-13 US disclosed
CN-1087092-A Novel 7 beta-substituted-4-aza-5 alpha-androstan-3-ones as 5 alpha-reductase inhibitors MERCK & CO INC (US) 1994-05-25 CN disclosed
EP-0572166-A1 New 7beta-substituted-4-aza-5a-androstan-3-ones as 5a-reductase inhibitors MERCK & CO. INC. (US) 1993-12-01 EP disclosed
WO-1993023420-A1 NEW 7β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS MERCK & CO., INC. (US) 1993-11-25 WO disclosed
WO-1993023039-A1 SUBSTITUTED 4-AZA-5A-ANDROSTAN-ONES AS 5A-REDUCTASE INHIBITORS MERCK & CO., INC. (US) 1993-11-25 WO disclosed
WO-1993023051-A1 NEW 17-ESTER, AMIDE, AND KETONE DERIVATIVES OF 3-OXO-4-AZASTEROIDS AS 5A-REDUCTASE INHIBITORS MERCK & CO., INC. (US) 1993-11-25 WO disclosed
EP-0544488-A2 Substituted phenyl phenol leukotriene antagonists ELI LILLY AND COMPANY (US) 1993-06-02 EP disclosed